arjunolic acid has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sherif, IO | 1 |
| Al-Gayyar, MM; Elsherbiny, NM | 1 |
| Bansal, T; Chatterjee, E; Kundu, B; Ray, A; Sarkar, S; Sengupta, S; Singh, J; Thankamani, V | 1 |
3 other study(ies) available for arjunolic acid and transforming growth factor beta
| Article | Year |
|---|---|
Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Adhesion Molecules; Cisplatin; Drug Evaluation, Preclinical; Kidney; Kidney Diseases; Kidney Function Tests; Male; NF-kappa B; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Terminalia; Transforming Growth Factor beta; Triterpenes | 2015 |
Anti-tumor activity of arjunolic acid against Ehrlich Ascites Carcinoma cells in vivo and in vitro through blocking TGF-β type 1 receptor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Ascites; Carcinoma, Ehrlich Tumor; Caspase 3; Cytokines; Female; Inflammation Mediators; Malondialdehyde; Mice; Models, Biological; Oxidative Stress; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta; Triterpenes | 2016 |
Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.
Topics: Animals; Cardiomegaly; Collagen; Fibrosis; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Myocardium; p38 Mitogen-Activated Protein Kinases; PPAR alpha; Rats; Rats, Wistar; Transcription Factor RelA; Transforming Growth Factor beta; Triterpenes | 2017 |